Targeting S -adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A

PF-9366 inhibits Mat2A by binding to an allosteric site that overlaps with the binding site of Mat2B, altering the active site and supporting a model in which Mat2B can be either an inhibitor or an activator of Mat2A, depending on methionine and SAM levels.